
Mindray
@MindrayGlobal
Followers
3K
Following
1K
Media
2K
Statuses
2K
Your official source on the latest updates of Mindray, the global medical solution provider.
Joined February 2017
Every mile Mindray travels bridges healthcare gaps and empowers communities. Join us in redefining impact: every mile matters. 💡 Watch our journey: .#BeyondMiles #ESG #GlobalImpact.
1
0
8
At Mindray's workshop @ADLM2025, together with Dr. Fred Apple and Dr. Zhang Yi, we explored core challenges and latest breakthroughs in myocardial injury. Learn more: #MindrayAtADLM2025 #ADLMWorkshop #MindrayDiagnostics #HighSensitivityCardiacTroponin
1
0
2
Early mobilisation and positional management are crucial in the ICU to enhance patient outcomes. Discover how the new MRV Pod™ cable-lite solution breaks free from tangled and unstructured cables. Find out more at #SeeBeyondYourVision
0
0
2
🚀 ADLM 2025 is Almost Here!.Join Mindray in Chicago, July 29–31, for breakthrough insights shaping the future of lab diagnostics.🔬 Industry Workshop .📊 Cutting-Edge Academic Posters .💡 Expert Talks . #MindrayAtADLM #BeyondTheWonder #LabMedicine #DiagnosticsInnovation
0
2
5
Unlocking Accuracy in Free Testosterone Testing!.Mindray's Free Testosterone CLIA Assay revolutionizes hormone analysis with simpler operation and strong correlation with gold-standard LC-MS/MS, delivering lab-grade precision you can trust. #FreeTestosterone #LC-MS/MS
1
0
2
The new #BeneVisionV Series now integrates POCUS directly into bedside hemodynamic assessment. Clinicians can visualize, analyse, and document both real-time and historical ultrasound findings directly through the monitors. More at #SeeBeyondYourVision
0
0
0
🎉 Congrats to Prof. Jun Xu & team on their JAMA Network Open study! Their research shows escalating energy #defibrillation (200–300–360 J) is more effective for #OHCA patients with VF, especially in tough cases. Check it out: . #EmergencyMedicine
0
0
1
🚀 Mindray is thrilled to launch the High-Sensitivity Troponin T (hs-cTnT) assay, enriching our Cardiac Marker panel! With superior detection rates and CV, it ensures accurate results for clinicians in diagnosing acute coronary syndrome (ACS). #CardiacMarkers #TroponinTest
0
1
3
In the ICU, patient interaction and early mobilisation can be hindered by equipment constraints. Enter the #BeneVisionV Series Patient Monitoring System — the industry's first full-parameter, cable-lite solution, ensuring seamless care at every stage. 🔗
0
0
1
Glad to be at the inaugural #tHIS The Healthcare Industry Series event in Kuala Lumpur, where we met friends old and new, and explored a better future together. #tHIS #HealthcareInnovation #Mindray #SmartHospital #ecosystem
0
0
2
Introducing #BeneVisionV Series Patient Monitoring - designed for comprehensive visibility and streamlined workflows across care environments. ✅Unparalleled 4K clarity on VMAX.✅360° visible alarm lights.✅ Effortless Control and Customisation.🔗
0
0
1
The Dragon Boat Festival is a time for our global family to connect! Colleagues dove into festivities: making zongzi, joining contests, and crafting traditions. Cheers to teamwork and shared joy! #DragonBoatFestival #TeamSpirit #GlobalTeam
0
0
2
Mindray's green initiatives in #labs: • Advanced tech • Extended reagent validity • Optimized designs. Explore more: #WorldEnvironmentDay #SustainableHealthcare #GreenLabs
0
0
2
The increasing utilisation of #POCUS in the ICU has transformed patient assessment. Here’s how #BeneVision V enhances your clinical practice:.✅ Real-time Ultrasound Imaging.✅ Retrospective Ultrasound Review.✅ Upgraded HemoSight™ Tool.🔗 Find more at
0
0
1
The curtain may fall on #WFUMB2025, but Mindray's mission to make advanced ultrasound care accessible remains unwavering. Watch the video and see how these sparks ignited in Kyoto fuel progress across global healthcare!
0
0
1
Mindray has achieved another breakthrough with groundbreaking research findings, “HD Scope⁺: A Comprehensive Solution Providing Detailed Diagnostic Information for Characteristics of Lesions,” unveiled at #WFUMB2025. This is more than just a study—it’s a game-changer!
0
0
4